MOBIUS THERAPEUTICS
Mobius Therapeutics is an early-stage venture focused on ophthalmic surgery solutions. Its first product, Mitosol, is a system for delivering antifibrotic agents in glaucoma, refractive, and corneal surgery. It is awaiting regulatory approval, with additional product applications in earlier stages of development.
MOBIUS THERAPEUTICS
Industry:
Biotechnology Life Science Medical Device Therapeutics
Founded:
2006-01-01
Address:
St Louis, Missouri, United States
Country:
United States
Website Url:
http://www.mobiustherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
3144505933
Email Addresses:
[email protected]
Total Funding:
8.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Apache Wordpress Plugins Sitelinks Search Box
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
Cultivation Capital
Cultivation Capital investment in Series B - Mobius Therapeutics
BioGenerator
BioGenerator investment in Venture Round - Mobius Therapeutics
Official Site Inspections
http://www.mobiustherapeutics.com
- Host name: mi3-sr6.supercp.com
- IP address: 68.66.200.218
- Location: Ann Arbor United States
- Latitude: 42.2503
- Longitude: -83.8393
- Metro Code: 505
- Timezone: America/Detroit
- Postal: 48106
More informations about "Mobius Therapeutics"
Mobius Therapeutics - Dedicated to Perioperative Pharmaceuticals …
Mobius Therapeutics’ vision is to lead in ophthalmic perioperative pharmaceuticals. Our mission is to identify challenging needs and innovate solutions that continually improve patient care, …See details»
Company Profile - Mobius Therapeutics
Mobius Therapeutics was founded in 2006 on the principle of resolution of challenges in the ophthalmic pharmaceutical market. It’s flagship product, Mitosol, was approved by FDA in …See details»
About Us - Mobius Therapeutics
With more than a century of combined experience in ophthalmology, the core management team of Mobius brings rock solid management and unmatched strategic vision to ophthalmic …See details»
Mobius Therapeutics Company Profile 2024: Valuation, Funding ...
Developer of mitomycin drugs intended to be used in various surgeries. The company's drugs provide antifibrotic agents to ophthalmic surgeons which can be used during glaucoma, …See details»
Mobius Therapeutics - Crunchbase Company Profile & Funding
Mobius Therapeutics is an early-stage venture focused on ophthalmic surgery solutions. Its first product, Mitosol, is a system for delivering antifibrotic agents in glaucoma, refractive, and …See details»
Mobius Therapeutics, LLC | LinkedIn
Mobius Therapeutics was founded in 2006 on the principle of resolution of challenges in the ophthalmic pharmaceutical market. It’s flagship product, Mitosol, was approved by FDA in 2012 and has...See details»
Mobius Therapeutics, LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Mobius Therapeutics, LLC of Saint Louis, MO. Get the latest business insights from Dun & Bradstreet.See details»
Mobius Therapeutics: Contact Details and Business Profile
Mobius Therapeuticsâ„¢ is a commercial stage venture focused upon perioperative sterile injectables used in ophthalmic surgery. Its first product, Mitosol®, is the only FDA approved …See details»
MOBIUS THERAPEUTICS, LLC. ST. LOUIS, MO - BisProfiles
Mobius Therapeutics, LLC Dedicated to helping ophthalmologists and their patients. With more than a century of combined experience in ophthalmology, the core management team of …See details»
Mobius Therapeutics, LLC | St. Louis, MO, USA Startup
Find investment information and connect with Mobius Therapeutics, LLC, a St. Louis, MO, USA based Biotechnology startup.See details»
Mobius Product Lineup - Mobius Therapeutics
Mobius Therapeutics is dedicated to developing sterile injectable pharmaceuticals optimized for ophthalmic applications.See details»
Mobius Therapeutics - LinkedIn
Wright Mark Chief Financial Officer at Mobius Therapeutics, LLC Linda Kalata Director of Clinical ApplicationsSee details»
Mobius Therapeutics Management Team | Org Chart - RocketReach
Mobius Therapeutics employs 7 employees. The Mobius Therapeutics management team includes Ed Timm (Founder, Chairman and Chief Executive Officer), Chris Patullo (VP …See details»
Carla Timm - Director, Customer Service & Sales Support at
She is the leading face of MobiusTM, responsible for every level of the customer experience, seeing to customer setup, individual customer and situational requirements, and coordination …See details»
MOBIUS THERAPEUTICS, LLC - OpenGovUS
MOBIUS THERAPEUTICS, LLC (SAM# KLJBPMB6M2C1) is an entity registered with U.S. General Services Administration (GSA), System for Award Management (SAM). The …See details»
Corporate Responsibility - Mobius Therapeutics
To request a copy of the Mobius Therapeutics, LLC Compliance Program Overview, please call our Customer Service Department at 1-314-615-6930 or submit an e-mail to …See details»
Mobius Therapeutics - Overview, News & Similar companies
May 10, 2022 · Mobius Therapeutics contact info: Phone number: (314) 615-6930 Website: www.mobiustherapeutics.com What does Mobius Therapeutics do? Mobius Therapeuticsâ„¢ is …See details»
Mobius Therapeutics CEO, Founder, Key Executive Team, Board of ...
Explore {Mobius Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Leiters® and Mobius Therapeutics™ Enter into National Sales and ...
Feb 15, 2019 · Denver, CO and St. Louis, MO, February 14, 2019 -– Leiters® and Mobius Therapeuticsâ„¢ announced today that they have entered into a national sales and marketing …See details»
Mobius Therapeutics - Dedicated to Perioperative Pharmaceuticals …
MMC is a toxic and potentially hazardous chemotherapeutic drug that must be handled with care to protect healthcare providers and patients. The following steps are recommended to prevent …See details»